Related references
Note: Only part of the references are listed.The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
Anne-Laure Mahul-Mellier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Hedgehog Signaling Modulates Glial Proteostasis and Lifespan
Andrew Rallis et al.
CELL REPORTS (2020)
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
Senthil T. Kumar et al.
NEUROBIOLOGY OF DISEASE (2020)
Cellular models of alpha-synuclein toxicity and aggregation
Marion Delenclos et al.
JOURNAL OF NEUROCHEMISTRY (2019)
The physiological role of α-synuclein and its relationship to Parkinson's Disease
David Sulzer et al.
JOURNAL OF NEUROCHEMISTRY (2019)
The nucleolus functions as a phase-separated protein quality control compartment
F. Frottin et al.
SCIENCE (2019)
Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression
Martin Bartels et al.
SCIENTIFIC REPORTS (2019)
Different Effects of α-Synuclein Mutants on Lipid Binding and Aggregation Detected by Single Molecule Fluorescence Spectroscopy and ThT Fluorescence-Based Measurements
Viktoria C. Ruf et al.
ACS CHEMICAL NEUROSCIENCE (2019)
In Vivo Protein Complementation Demonstrates Presynaptic α-Synuclein Oligomerization and Age-Dependent Accumulation of 8-16-mer Oligomer Species
Martin Kiechle et al.
CELL REPORTS (2019)
Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit alpha-Synuclein Aggregation and Facilitate its Degradation
Yuan Zheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice
Waijiao Cai et al.
EBIOMEDICINE (2018)
Secretion and Uptake of -Synuclein Via Extracellular Vesicles in Cultured Cells
Gabriel Gustafsson et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
An enhanced recombinant amino-terminal acetylation system and novel in vivo high-throughput screen for molecules affecting α-synuclein oligomerisation
Tara A. Eastwood et al.
FEBS LETTERS (2017)
Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor
Soheila Mohammadi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
The Synucleinopathies: Twenty Years On
Michel Goedert et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function
Dong-Kyu Kim et al.
AUTOPHAGY (2016)
Effect of Acidic pH on the Stability of α-Synuclein Dimers
Zhengjian Lv et al.
BIOPOLYMERS (2016)
Lighting the Way to Protein-Protein Interactions: Recommendations on Best Practices for Bimolecular Fluorescence Complementation Analyses
Joerg Kudla et al.
PLANT CELL (2016)
Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease
Mohamed-Bilal Fares et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity
Susana A. Goncalves et al.
PLOS GENETICS (2016)
A Rapid, Semi-Quantitative Assay to Screen for Modulators of Alpha-Synuclein Oligomerization Ex vivo
Marion Delenclos et al.
FRONTIERS IN NEUROSCIENCE (2016)
The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
Diana F. Lazaro et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Dimerization propensities of Synucleins are not predictive for Synuclein aggregation
Katrin Eckermann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Direct Detection of α-Synuclein Dimerization Dynamics: Single-Molecule Fluorescence Analysis
Zhengjian Lv et al.
BIOPHYSICAL JOURNAL (2015)
Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain
Rosalind F. Roberts et al.
BRAIN (2015)
Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies
Simon Moussaud et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Prolyl Oligopeptidase Enhances α-Synuclein Dimerization via Direct Protein-Protein Interaction
Mari H. Savolainen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Parkinson Disease Mutant E46K Enhances α-Synuclein Phosphorylation in Mammalian Cell Lines, in Yeast, and in Vivo
Martial Kamdem Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein
Maria K. Janowska et al.
SCIENTIFIC REPORTS (2015)
Structure based aggregation studies reveal the presence of helix-rich intermediate during alpha-Synuclein aggregation
Dhiman Ghosh et al.
SCIENTIFIC REPORTS (2015)
α-Synuclein Multimers Cluster Synaptic Vesicles and Attenuate Recycling
Lina Wang et al.
CURRENT BIOLOGY (2014)
Alpha-Synuclein Transfers from Neurons to Oligodendrocytes
Juan F. Reyes et al.
GLIA (2014)
The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells
Mohamed-Bilal Fares et al.
HUMAN MOLECULAR GENETICS (2014)
The H50Q Mutation Enhances α-Synuclein Aggregation, Secretion, and Toxicity
Ossama Khalaf et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Noninvasive Bioluminescence Imaging of α-Synuclein Oligomerization in Mouse Brain Using Split Firefly Luciferase Reporters
Sarah-Ann Aelvoet et al.
JOURNAL OF NEUROSCIENCE (2014)
DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease
L. Zondler et al.
CELL DEATH & DISEASE (2014)
Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation
Diana F. Lazaro et al.
PLOS GENETICS (2014)
α-Synuclein Misfolding Assessed with Single Molecule AFM Force Spectroscopy: Effect of Pathogenic Mutations
Alexey V. Krasnoslobodtsev et al.
BIOCHEMISTRY (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Behavioral Characterization of A53T Mice Reveals Early and Late Stage Deficits Related to Parkinson's Disease
Katrina L. Paumier et al.
PLOS ONE (2013)
Direct detection of alpha synuclein oligomers in vivo
Hemi Dimant et al.
Acta Neuropathologica Communications (2013)
α-Synuclein modifies huntingtin aggregation in living cells
Federico Herrera et al.
FEBS LETTERS (2012)
α-Synuclein in Central Nervous System and from Erythrocytes, Mammalian Cells, and Escherichia coli Exists Predominantly as Disordered Monomer
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exosomal cell-to-cell transmission of alpha synuclein oligomers
Karin M. Danzer et al.
MOLECULAR NEURODEGENERATION (2012)
Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity
Karin M. Danzer et al.
FASEB JOURNAL (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Brain-Permeable Small-Molecule Inhibitors of Hsp90 Prevent α-Synuclein Oligomer Formation and Rescue α-Synuclein-Induced Toxicity
Preeti Putcha et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Zooming into protein oligomerization in neurodegeneration using BiFC
Susana A. Goncalves et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Biomolecular fluorescence complementation (BiFC) analysis as a probe of protein interactions in living cells
Tom K. Kerppola
ANNUAL REVIEW OF BIOPHYSICS (2008)
CHIP targets toxic α-synuclein oligomers for degradation
Julie E. Tetzlaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Formation of Toxic Oligomeric α-Synuclein Species in Living Cells
Tiago Fleming Outeiro et al.
PLOS ONE (2008)
Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells
Tom K. Kerppola
NATURE PROTOCOLS (2006)
Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: Scope and mechanism
TJ Magliery et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
Clearance of α-synuclein oligomeric intermediates via the lysosomal degradation pathway
HJ Lee et al.
JOURNAL OF NEUROSCIENCE (2004)
Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis
CD Hu et al.
NATURE BIOTECHNOLOGY (2003)
Oxidative dimer formation is the critical rate-limiting step for Parkinson's disease α-synuclein fibrillogenesis
S Krishnan et al.
BIOCHEMISTRY (2003)
Characterization of cytoplasmic α-synuclein aggregates -: Fibril formation is tightly linked to the inclusion-forming process in cells
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Visualization of interactions among bZip and Rel family proteins in living cells using bimolecular fluorescence complementation
CD Hu et al.
MOLECULAR CELL (2002)
Share Paper
